Indivior, PLC (NASDAQ: INDV)

This lawsuit is for anyone who acquired securities in Indivior, PLC (NASDAQ: INDV) from February 22, 2024 through July 8, 2024.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors by issuing positive guidance without a reasonable basis for doing so considering that the Company knew pending legislation was likely to impact the profitability of the Company’s schizophrenia treatment, PERSERIS.

On July 9, 2024, Indivior disclosed that it would be immediately ceasing all sales and marketing activities related to its schizophrenia treatment, PERSERIS due to the highly competitive market “and impending changes that are expected to intensify payor management in the treatment category in which PERSERIS participates.” Additionally, the Company significantly reduced its 2024 net revenue guidance. On this news, the price of the Company’s stock again dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Indivior, PLC (NASDAQ: INDV) from February 22, 2024 through July 8, 2024 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.